![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
SIMULTANEOUS ESTIMATION OF ALOGLIPTIN BENZOATE AND PIOGLITAZONE HYDROCHLORIDE IN TABLET DOSAGE FORM USING UV-SPECTROSCOPY AND REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Himani Gururani*, Ram Nivas, Monika Patel and Shamim Khan
ABSTRACT
Tablets are solid preparations that are nearly usually meant to be used orally, each containing a single dose of one or more active substances. They are made by compressing consistent quantities of particles. The most widely recommended dosage form is a tablet because it is a practical way to administer medication, has consistent dosage across tablets, is stable under a range of long-term storage conditions, and can be made using high-speed labeling, packing, and compression equipment. Because of this, advancements in tablet production technology are continuously being made to better their capacity to precisely administer a desired medicine in a dose form meant to have either immediate or long-term therapeutic effects.[1] The goal of standard compressed tablet modifications and technological advancements is to improve bioavailability and acceptance. In order to Keywords: . [Download Article] [Download Certifiate] |